Allergic conjunctivitis classification

Jump to navigation Jump to search

Allergic conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Allergic Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Allergic conjunctivitis classification On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Allergic conjunctivitis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Allergic conjunctivitis classification

CDC on Allergic conjunctivitis classification

Allergic conjunctivitis classification in the news

Blogs on Allergic conjunctivitis classification

Directions to Hospitals Treating Allergic conjunctivitis

Risk calculators and risk factors for Allergic conjunctivitis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Classification

SAC and PAC

Both seasonal allergic conjunctivitis and perennial allergic conjunctivitis are two acute allergic conjunctival disorders.[1] SAC is the most common ocular allergy.[2][3] Symptoms of the aforementioned ocular diseases include itching and pink to reddish eye(s).[1] These two eye conditions are mediated by mast cells.[1][3] Nonspecific measures to ameliorate symptoms include cold compresses, eyewashes with tear substitutes, and avoidance of allergens.[1] Treatment consists of antihistamine, mast cell stabilizers, dual mechanism anti-allergen agents, or topical antihistamines.[1] Corticosteroids are another option, but, considering the side-effects of cataracts and increased intraocular pressure, corticosteroids are reserved for more severe forms of allergic conjunctivitis such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC).[1]

VKC and AKC

Both vernal keratoconjunctivitis and atopic keratoconjunctivitis are chronic allergic diseases wherein eosinophils, conjunctival fibroblasts, epithelial cells, mast cells, and TH2 lymphocytes aggravate the biochemistry and histology of theconjunctiva.[1] VKC is a disease of childhood and is prevalent in males living in warm climates.[1] AKC is frequently observed in males between the ages of 30 and 50.[1] VKC and AKC can be treated by medications used to combat allergic conjunctivitis or the use of steroids.[1]

Giant Papillary Conjunctivitis

Giant papillary conjunctivitis is not a true ocular allergic reaction and is caused by repeated mechanical irritation of the conjunctiva.[1] Repeated contact with the conjunctival surface caused by the use of contact lenses is associated with GPC.[3]

Phlyctenular keratoconjunctivitis

PKC results from a hypersensitivity/inflammatory reaction to bacteria. Common pathogens include Staph. aureus, Mycobacterium tuberculosis, Chlamydia and Candida.

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Ono SJ, Abelson MB (2005). "Allergic conjunctivitis: update on pathophysiology and prospects for future treatment". J. Allergy Clin. Immunol. 115 (1): 118–22. doi:10.1016/j.jaci.2004.10.042. PMID 15637556. Unknown parameter |month= ignored (help)
  2. 3.0 3.1 3.2 Buckley RJ (1998). "Allergic eye disease—a clinical challenge". Clin. Exp. Allergy. 28 (Suppl 6): 39–43. doi:10.1046/j.1365-2222.1998.0280s6039.x. PMID 9988434. Unknown parameter |month= ignored (help)

Template:WH Template:WS